Union Government launched BIRSA 101, India's first indigenous CRISPR gene therapy targeting Sickle Cell Disease. Developed by CSIR-IGIB and SII, this affordable enFnCas9 technology primarily benefits tribal communities, accelerating the National Sickle Cell Elimination Mission 2047
Click to View MoreAMT-130 gene therapy reduces Huntington’s disease progression by 75% over three years via a single injection silencing the mutant gene. This breakthrough redefines treatment, inspiring hope while raising cost-accessibility challenges under India’s Rare Disease Policy.
Click to View More
© 2026 iasgyan. All right reserved